SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-007732
Filing Date
2021-02-09
Accepted
2021-02-09 16:00:57
Documents
2
Period of Report
2021-02-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 9201
2 POWER OF ATTORNEY ea134955ex24_geminitherap.htm EX-24 7015
  Complete submission text file 0001213900-21-007732.txt   17633
Mailing Address 3052 PACIFIC AVENUE SAN FRANCISCO CA 94115
Business Address
Tananbaum James B. (Reporting) CIK: 0001581754 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39438 | Film No.: 21606306

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Issuer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations